With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

The United States government has discontinued its free at-home COVID-19 test program after four years. The program, which began in 2021, shipped over 900 million tests directly to U.S. households.